Metformin inhibits Aβ25-35 -induced apoptotic cell death in SH-SY5Y cells
Li-Xia Li1, Meng-Yu Liu1, Xue Jiang1
1Department of Zoology and Developmental Biology, College of Life Sciences, Nankai University, Tianjin, China.
Abstract:
Metformin, a first-line drug for type-2 diabetes, plays a potentially protective role in preventing Alzheimer's disease (AD), but its underlying mechanism is unclear. In this study, Aβ25-35 -treated SH-SY5Y cells were used as a cell model of AD to investigate the neuroprotective effect of metformin, as well as its underlying mechanisms. We found that metformin decreased the cell apoptosis rate and death, ratio of Bcl-2/Bax, and expression of NR2A and NR2B, and increased the expression of LC3 in Aβ25-35 -treated SH-SY5Y cells. Metformin also reduced intracellular and extracellular Glu concentrations, as well as the intracellular concentration of Ca2+ and ROS in Aβ25-35 -treated SH-SY5Y cells. These findings suggest that metformin inhibits Aβ25-35 -treated SH-SY5Y cell death by inhibiting apoptosis, decreasing intracellular Ca2+ and ROS by reducing neurotoxicity of excitatory amino acids, and by possibly reversing autophagy disorder via regulating autophagy process.
Insights
Metformin may protect against Alzheimer's disease (AD) by reducing cell death and improving cellular processes. This study investigated its neuroprotective effects and mechanisms in an AD cell model.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Type-2 diabetes drug Metformin shows potential in preventing Alzheimer's disease (AD).
- The precise mechanisms behind Metformin's neuroprotective effects in AD remain largely unknown.
- Alzheimer's disease is characterized by neuronal damage and dysfunction.
Purpose of the Study:
- To investigate the neuroprotective effects of Metformin in an Alzheimer's disease (AD) cell model.
- To elucidate the underlying molecular mechanisms of Metformin's action in AD.
Main Methods:
- Utilized SH-SY5Y cells treated with amyloid-beta (Aβ) 25-35 as an in vitro model for AD.
- Assessed cell apoptosis, cell death, protein expression (Bcl-2, Bax, NR2A, NR2B, LC3), and levels of glutamate (Glu), calcium (Ca2+), and reactive oxygen species (ROS).
Main Results:
- Metformin significantly decreased apoptosis and cell death in Aβ-treated cells.
- Metformin altered the expression of key proteins involved in apoptosis and autophagy (Bcl-2/Bax ratio, LC3).
- Metformin reduced intracellular/extracellular glutamate, intracellular Ca2+, and ROS levels, mitigating excitotoxicity and oxidative stress.
Conclusions:
- Metformin demonstrates neuroprotective effects against Aβ-induced neurotoxicity in SH-SY5Y cells.
- Mechanisms include inhibition of apoptosis, reduction of intracellular Ca2+ and ROS via decreased excitotoxicity, and potential regulation of autophagy.
- Metformin's multifaceted action suggests a promising therapeutic avenue for Alzheimer's disease.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Feedback Inhibition


